Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-424428 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,000
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Shares | โ | Oct 15, 2026 | Exercise/Conversion | 7,500 | โ | โ | 22,500 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Share Units | Derivative | Oct 15, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 22,500 | Direct | โ | View Details |